Literature DB >> 9152024

Activation of the beta2 integrin Mac-1 (CD11b/CD18) by an endogenous lipid mediator of human neutrophils and HL-60 cells.

K Klugewitz1, K Ley, D Schuppan, R Nuck, P Gaehtgens, B Walzog.   

Abstract

beta2 integrins (CD11/CD18) play a key role in the adhesion, activation, migration and phagocytosis of human neutrophils. In order to exert their functions, beta2 integrins require activation, which results in an enhancement of ligand affinity. This functional up-regulation is probably due to a conformational change of the beta2 integrins, but the mechanisms of inside-out signaling that trigger this activation are still under investigation. In the present study, the effect of cellular lipids on the affinity state of beta2 integrins was investigated. Lipids were extracted from human neutrophils and HL-60 cells after stimulation with IL-8 or phorbol ester, respectively. The extracts were purified by anion exchange chromatography and/or HPLC fractionation. The lipid extracts induced the adhesion of neutrophils to fibrinogen and, in a cell-free assay system, the binding of C3bi-coated zymosan-particles by purified beta2 integrin Mac-1 (CD11b/CD18). The integrin up-regulating activity was resistant to ester hydrolysis, eluted as one particular HPLC-fraction, and showed an absorption maximum at 194+/-2 nm. Taken together, these data support the concept that activated neutrophils and HL-60 cells can generate an endogenous lipid mediator, which up-regulates ligand binding activity of beta2 integrins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152024     DOI: 10.1242/jcs.110.8.985

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  2 in total

1.  Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils.

Authors:  A T Tool; M Blom; D Roos; A J Verhoeven
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis.

Authors:  Annabelle Cesaro; Nadia Anceriz; Audrey Plante; Nathalie Pagé; Mélanie R Tardif; Philippe A Tessier
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.